Brexit and Research
Researchers within the UK have over the years benefitted from access to European Union (EU) funding streams, such as FP7 and Horizon 2020, and learning opportunities through programmes such as Erasmus+.
Access to any future European funding streams is essential to enable successful collaborations to continue; clinical research is a key component of NHS activity across the UK and the NHS also has a long tradition of EU collaborative research.
The UK has a globally recognised research community; with 0.9% of the world’s population, and 3.2% of its R&D spend, the UK produces 15.9% of its most important research output. The UK’s strong reputation for research should remain unaffected by the forthcoming departure from the EU.